Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice
-
Published:2024-05-08
Issue:6
Volume:24
Page:527-538
-
ISSN:1530-7905
-
Container-title:Cardiovascular Toxicology
-
language:en
-
Short-container-title:Cardiovasc Toxicol
Author:
Mowaad Noha A.ORCID, Elgohary Rania, ElShebiney Shaimaa
Abstract
AbstractAdolescents commonly co-abuse many drugs including anabolic androgenic steroids either they are athletes or non-athletes. Stanozolol is the major anabolic used in recent years and was reported grouped with cannabis. The current study aimed at evaluating the biochemical and histopathological changes related to the hypertrophic effects of stanozolol and/or cannabis whether in condition of exercise practice or sedentary conditions. Adult male Wistar albino rats received either stanozolol (5 mg/kg, s.c), cannabis (10 mg/kg, i.p.), and a combination of both once daily for two months. Swimming exercise protocol was applied as a training model. Relative heart weight, oxidative stress biomarkers, cardiac tissue fibrotic markers were evaluated. Left ventricular morphometric analysis and collagen quantification was done. The combined treatment exhibited serious detrimental effects on the heart tissues. It increased heart tissue fibrotic markers (Masson’s trichrome stain (p < 0.001), cardiac COL3 (p < 0.0001), and VEGF-A (p < 0.05)), lowered heart glutathione levels (p < 0.05) and dramatically elevated oxidative stress (increased malondialdehyde (p < 0.0001) and 8-OHDG (p < 0.0001)). Training was not ameliorating for the observed effects. Misuse of cannabis and stanozolol resulted in more hypertrophic consequences of the heart than either drug alone, which were at least largely assigned to oxidative stress, heart tissue fibrotic indicators, histological alterations, and morphometric changes.
Funder
National Research Centre Egypt
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Kennedy, M. C. (2017). Cannabis: exercise performance and sport. A systematic review. Journal of Science and Medicine in Sport, 20(9), 825–829. 2. Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M., & Kleijnen, J. (2015). Cannabinoids for medical use. JAMA, 313(24), 2. 3. Zeiger, J. S., Silvers, W. S., Fleegler, E. M., & Zeiger, R. S. (2019). Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes. Journal of Cannabis Research. https://doi.org/10.1186/s42238-019-0006-9 4. Brisola-Santos, M. B., Gallinaro, J. G. D. M. E., Gil, F., Sampaio-Junior, B., Marin, M. C. D., De Andrade, A. G., Richter, K. P., Glick, I. D., Baltieri, D. A., & Castaldelli-Maia, J. M. (2016). Prevalence and correlates of cannabis use among athletes—A systematic review. American Journal on Addictions, 25(7), 518. 5. Burr, J. F., Cheung, C. P., Kasper, A. M., Gillham, S. H., & Close, G. L. (2021). Cannabis and athletic performance. Sports Medicine (Auckland, N. Z.), 51(Suppl 1), 75.
|
|